Location History:
- Strattford, PA (US) (2001 - 2002)
- Strafford, PA (US) (1999 - 2008)
Company Filing History:
Years Active: 1999-2008
Title: Jason Craig Fedon: Innovator in Staphylococcal Research
Introduction
Jason Craig Fedon, located in Strafford, PA, is a prolific inventor with a remarkable portfolio that includes 19 patents. His work primarily focuses on the field of microbiology, particularly the identification and utilization of Staphylococcal polynucleotides and polypeptides, paving the way for innovative therapeutic applications.
Latest Patents
Among his latest innovations, Jason has developed two notable patents related to newly identified Staphylococcal polynucleotides and polypeptides. These inventions explore the uses of such polynucleotides and polypeptides, the processes for their production, and the design of recombinant host cells transformed with these polynucleotides. Furthermore, his research delves into methods for inhibiting the biosynthesis or action of these compounds, highlighting their potential application in therapeutic contexts.
Career Highlights
Jason's career includes significant contributions while working at SmithKline Beecham Corporation, where he honed his skills in research and development. With a strong foundation in microbiology and genetics, he has focused his efforts on unlocking the therapeutic possibilities presented by Staphylococcal compounds, making advancements that could lead to groundbreaking treatments.
Collaborations
Throughout his career, Jason has collaborated with esteemed professionals in the field, including Leslie Marie Palmer and Richard Lloyd Warren. These partnerships have enriched his research and allowed for the exchange of innovative ideas, further propelling advancements in the life sciences.
Conclusion
In conclusion, Jason Craig Fedon stands out as a dedicated inventor whose innovative work on Staphylococcal polynucleotides and polypeptides holds promise for future therapies. With 19 patents to his name and a career marked by collaboration and significant contributions, he continues to impact the field of microbiology and therapeutic research substantially.